Yang et al. showed that the expression level ADPGK-AS1 in the adjacent non-tumor tissues of patients with breast cancer was lower than in the tumor tissues, which might be regarded as an indicator for the prognosis of breast cancer patients because ADPGK-AS1 could facilitate cell proliferation and migration, suppress cell apoptosis, and induce epithelial-mesenchymal transition [30]. Here, ADPGK is linked to breast carcinoma.